Medical Condition News

RSS

Daiichi Sankyo submits LIXIANA supplemental NDA for review in Japan

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a supplemental New Drug Application for its oral, once-daily direct factor Xa-inhibitor LIXIANA® (Edoxaban Tosilate Hydrate) for review by the Japanese Ministry of Health, Labour and Welfare. Daiichi Sankyo is seeking approval in Japan for edoxaban in new indications for non-valvular atrial fibrillation and symptomatic venous thromboembolism.

19 Dec 2013

Tryton Medical launches Bifurcation Institute to advance care for bifurcated coronary artery disease

Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced the launch of the Bifurcation Institute. The Bifurcation Institute is a comprehensive education resource established to advance the standard of care for bifurcated coronary artery disease, a common, and often untreated, clinical need.

19 Dec 2013

Study investigates about emotions that affects patients with Parkinson's disease

Is it the disease itself or the treatment that impairs the perception of emotions? A study conducted with the collaboration of the International School for Advanced Studies (SISSA) of Trieste investigates the origins of the difficulty recognizing certain emotions that affects patients with Parkinson's disease.

19 Dec 2013

Inactive patients following cardiac surgery have higher risk of depression

New research indicates that inactive patients following cardiac surgery have a substantially higher risk of depression and that the number of patients suffering from depression after cardiac surgery is as high as 40%. Investigators recommend that cardiac patients should be assessed for depression and level of physical activity and remain as active as they safely can after surgery to minimize post-operative depression. The results are published in the December issue of the Canadian Journal of Cardiology.

19 Dec 2013

Bristol-Myers Squibb signs agreement to sell global diabetes business

Bristol-Myers Squibb Company today announced that it has signed an agreement to sell its global diabetes business that was part of its collaboration with AstraZeneca. Under terms of the agreement, AstraZeneca will make an upfront payment of $2.7 billion to Bristol-Myers Squibb, with potential regulatory- and sales-based milestone payments of up to $1.4 billion and will make royalty payments based on net sales through 2025.

19 Dec 2013

Abramson Cancer Center of the University of Pennsylvania celebrates 40th anniversary

This December marks the 40th anniversary of the Abramson Cancer Center of the University of Pennsylvania being designated a Comprehensive Cancer Center by the National Cancer Institute. To celebrate this momentous milestone, over 400 people gathered together early this month for an event recognizing the center's vast achievements in cancer research, patient care, and education during the last four decades.

19 Dec 2013

UT Southwestern receives $10M grant to find effective treatments for alcoholic hepatitis

UT Southwestern Medical Center has launched the local arm of a national, multicenter study aimed at finding more effective treatments for alcoholic hepatitis, a disease of the liver that often leads to cirrhosis and death in severe cases.

19 Dec 2013

ATS Foundation, American Lung Association to co-fund $80,000 grant to support HPS research

The American Thoracic Society Foundation and the American Lung Association announced today that they are co-funding an $80,000 grant that will support important research into the mechanisms underlying Hermansky-Pudlak syndrome, a rare inherited disease which affects a number of organs including the lungs.

19 Dec 2013

Poor people, minorities appear to suffer from sleep problems, chronic disease

Poor people and minorities appear to disproportionately suffer from problems with sleep and chronic disease, but the two do not appear to be directly linked, finds a new study in Ethnicity & Disease.

19 Dec 2013

Helsinn, Mundipharma sign distribution and license agreement for investigational therapy

Helsinn and Mundipharma announce the signature of a new, exclusive license and distribution agreement, covering China, Hong Kong and Macao, for netupitant-palonosetron fixed dose combination, a Helsinn product under development for the treatment of chemotherapy-induced nausea and vomiting.

19 Dec 2013

Co-culture with mesenchymal stem cells results in improved viability, function of human hepatocytes

Hepatocyte transplantation is becoming an accepted therapy for acute liver failure, either for liver regeneration or as a bridge to liver transplantation. However, maintaining the viability and functional aspects of hepatocytes has been a concern even with successful freezing.

19 Dec 2013

Scientists report new development toward long-sought insulin pill for diabetes treatment

Since insulin's crucial discovery nearly a century ago, countless diabetes patients have had to inject themselves with the life-saving medicine. Now scientists are reporting a new development toward a long-sought insulin pill that could save millions the pain of daily shots. Published in the ACS journal Biomacromolecules, the advance could someday not only eliminate the "ouch" factor, but also get needle-wary - and weary - patients to take their medicine when they should.

19 Dec 2013

Sanofi and Regeneron Pharmaceuticals team up with ACC to enhance clinical research with alirocumab

Sanofi and Regeneron Pharmaceuticals, Inc. today announced an innovative collaboration with the American College of Cardiology focused on enhancing clinical research with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). PCSK9 is known to contribute to circulating low-density lipoprotein cholesterol (LDL-C) levels. Alirocumab is being co-developed by Sanofi and Regeneron.

19 Dec 2013

New surface treatment processes for orthopaedic and dental implants to reduce risk of infection

Researchers at Aalto University have developed a method of selection of new surface treatment processes for orthopaedic and dental implants to reduce the risk of infection.

19 Dec 2013

Osteoarthritis patients can carry out progressive exercise to maintain bone health

The postmenopausal women who may be at risk of osteoporosis (bone loss), as well as at risk of osteoarthritis, can safely carry out progressive high-impact training to maintain bone health and physical function.

19 Dec 2013

Researchers use 3D technology from film industry to analyze rehabilitation for stroke patients

Researchers in Gothenburg have been using 3D technology from the film industry to analyze the everyday movements of stroke patients. The results, which are reported in a doctoral thesis at the Sahlgrenska Academy, indicate that computerized motion analysis increases our knowledge of how stroke patients can improve their ability to move through rehabilitation.

19 Dec 2013

Deep brain stimulation may have beneficial effect on driving ability for Parkinson's disease patients

Deep brain stimulation may have a beneficial effect on driving ability for people with Parkinson's disease, according to a new study published in the December 18, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. Deep brain stimulation uses a surgical implant similar to a pacemaker to send electrical impulses to the brain.

19 Dec 2013

Study reveals why people are predisposed to cardiovascular disease and death

A genetic trait known to make some people especially sensitive to stress also appears to be responsible for a 38 percent increased risk of heart attack or death in patients with heart disease, scientists at Duke Medicine report.

19 Dec 2013

Cells grown in ISS could help patients recover from stroke, says Mayo Clinic researcher

Abba Zubair, M.D., Ph.D, believes that cells grown in the International Space Station could help patients recover from a stroke, and that it may even be possible to generate human tissues and organs in space. He just needs a chance to demonstrate the possibility.

19 Dec 2013

People with intermittent explosive disorder elevate levels of markers of systemic inflammation in blood

People with intermittent explosive disorder — a psychiatric illness characterized by impulsivity, hostility and recurrent aggressive outbursts — have elevated levels of two markers of systemic inflammation in their blood, according to a study involving nearly 200 subjects.

19 Dec 2013

Medical Condition News

Daiichi Sankyo submits LIXIANA supplemental NDA for review in Japan

Tryton Medical launches Bifurcation Institute to advance care for bifurcated coronary artery disease

Study investigates about emotions that affects patients with Parkinson's disease

Inactive patients following cardiac surgery have higher risk of depression

Bristol-Myers Squibb signs agreement to sell global diabetes business

Abramson Cancer Center of the University of Pennsylvania celebrates 40th anniversary

UT Southwestern receives $10M grant to find effective treatments for alcoholic hepatitis

ATS Foundation, American Lung Association to co-fund $80,000 grant to support HPS research

Poor people, minorities appear to suffer from sleep problems, chronic disease

Helsinn, Mundipharma sign distribution and license agreement for investigational therapy

Co-culture with mesenchymal stem cells results in improved viability, function of human hepatocytes

Scientists report new development toward long-sought insulin pill for diabetes treatment

Sanofi and Regeneron Pharmaceuticals team up with ACC to enhance clinical research with alirocumab

New surface treatment processes for orthopaedic and dental implants to reduce risk of infection

Osteoarthritis patients can carry out progressive exercise to maintain bone health

Researchers use 3D technology from film industry to analyze rehabilitation for stroke patients

Deep brain stimulation may have beneficial effect on driving ability for Parkinson's disease patients

Study reveals why people are predisposed to cardiovascular disease and death

Cells grown in ISS could help patients recover from stroke, says Mayo Clinic researcher

People with intermittent explosive disorder elevate levels of markers of systemic inflammation in blood

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News